Glaxosmithkline Share Price | |
---|---|
Price | 1,797.50 |
Bid | 1,797.50 |
Ask | 1,798.00 |
Change | 17.00 (0.95%) |
Volume | 1,785,558 |
Open | 1,784.00 |
High | 1,798.00 |
Low | 1,780.00 |
Prev. Close | 1,780.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.08b |
Market Capitalisation | £73.30b |
Market Size | 1,500 |
52 Week High | 1,798.00 |
52 Week High Date | 10-May-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 5,324 |
---|---|
Vol. Sold | 927,986 |
Sold Value | £16.63m |
Vol. Bought | 742,924 |
Bought Value | £13.31m |
PE Ratio | 14.78207 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.088% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
10-May-24 | 15:52:12 | 1,797.50 | 320 | Sell* | 1,797.50 | 1,798.00 | 5,752 | O Ordinary Trade was executed as an SI |
10-May-24 | 15:52:12 | 1,798.00 | 5 | Buy* | 1,797.50 | 1,798.00 | 89.90 | O Ordinary Trade was executed as an SI |
10-May-24 | 15:51:35 | 1,797.405 | 1,807 | Sell* | 1,797.00 | 1,798.00 | 32.48k | O Ordinary |
10-May-24 | 15:51:32 | 1,797.50 | 1,005 | Buy* | 1,797.00 | 1,798.00 | 18.06k | O Ordinary Trade was executed as an SI |
10-May-24 | 15:51:32 | 1,797.50 | 194 | Buy* | 1,797.00 | 1,798.00 | 3,487 | A Automatic Execution |
10-May-24 | 15:51:05 | 1,797.00 | 320 | Sell* | 1,797.00 | 1,797.50 | 5,750 | O Ordinary Trade was executed as an SI |
10-May-24 | 15:50:37 | 1,797.00 | 231 | Sell* | 1,797.00 | 1,797.50 | 4,151 | A Automatic Execution |
10-May-24 | 15:50:37 | 1,797.00 | 69 | Sell* | 1,797.00 | 1,797.50 | 1,240 | A Automatic Execution |
10-May-24 | 15:50:37 | 1,797.00 | 209 | Sell* | 1,797.00 | 1,797.50 | 3,756 | A Automatic Execution |
10-May-24 | 15:50:37 | 1,797.00 | 91 | Sell* | 1,797.00 | 1,797.50 | 1,635 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Vishal Sikka held the position of Independent Non-Executive Director at the time of this trade.Vishal Sikka | 40.96 | USD | 43 | 253,466,508 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Jesse Goodman held the position of Independent Non-Executive Director at the time of this trade.Jesse Goodman | 40.96 | USD | 9 | 11,157 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
At GSK, we unite science, technology and talent to get ahead of disease together